Including 209 pathway commons in ASD, 31 in ID, 130 in EE and 190 in SCZ. |
pc accession | pc pathway name | Number of reference genes | Number of genes | Expected number | Ratio of entrichment | Raw P_Value | Adjusted P_Value | Genes related | Other disease |
---|---|---|---|---|---|---|---|---|---|
DB_ID:1517 | Beta1 integrin cell surface interactions | 1351 | 37 | 8.77 | 4.22 | 1.92e-13 | 4.48e-11 | ID ASD | |
DB_ID:1499 | Integrin family cell surface interactions | 1378 | 37 | 8.95 | 4.14 | 3.47e-13 | 4.48e-11 | ID ASD | |
DB_ID:1619 | Endothelins | 1307 | 34 | 8.49 | 4.01 | 8.07e-12 | 5.31e-10 | ID ASD | |
DB_ID:1649 | LKB1 signaling events | 1308 | 34 | 8.49 | 4.00 | 8.24e-12 | 5.31e-10 | ID ASD | |
DB_ID:1459 | Glypican pathway | 1338 | 34 | 8.69 | 3.91 | 1.52e-11 | 7.84e-10 | ID ASD | |
DB_ID:1556 | Plasma membrane estrogen receptor signaling | 1301 | 33 | 8.45 | 3.91 | 3.25e-11 | 9.08e-10 | ID ASD | |
DB_ID:1575 | VEGF and VEGFR signaling network | 1304 | 33 | 8.47 | 3.90 | 3.45e-11 | 9.08e-10 | ID ASD | |
DB_ID:1516 | Signaling events mediated by VEGFR1 and VEGFR2 | 1296 | 33 | 8.41 | 3.92 | 2.94e-11 | 9.08e-10 | ID ASD | |
DB_ID:1492 | Glypican 1 network | 1299 | 33 | 8.43 | 3.91 | 3.12e-11 | 9.08e-10 | ID ASD | |
DB_ID:1578 | Alpha9 beta1 integrin signaling events | 1305 | 33 | 8.47 | 3.89 | 3.52e-11 | 9.08e-10 | ID ASD | |
DB_ID:1564 | IL3-mediated signaling events | 1295 | 32 | 8.41 | 3.81 | 1.27e-10 | 9.76e-10 | ID ASD | |
DB_ID:1454 | Syndecan-1-mediated signaling events | 1300 | 32 | 8.44 | 3.79 | 1.40e-10 | 9.76e-10 | ID ASD | |
DB_ID:1497 | PDGF receptor signaling network | 1293 | 32 | 8.39 | 3.81 | 1.23e-10 | 9.76e-10 | ID ASD | |
DB_ID:1574 | Signaling events mediated by focal adhesion kinase | 1288 | 32 | 8.36 | 3.83 | 1.11e-10 | 9.76e-10 | ID ASD | |
DB_ID:1466 | Insulin Pathway | 1288 | 32 | 8.36 | 3.83 | 1.11e-10 | 9.76e-10 | ID ASD | |
DB_ID:1491 | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) | 1293 | 32 | 8.39 | 3.81 | 1.23e-10 | 9.76e-10 | ID ASD | |
DB_ID:1519 | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | 1288 | 32 | 8.36 | 3.83 | 1.11e-10 | 9.76e-10 | ID ASD | |
DB_ID:1540 | PDGFR-beta signaling pathway | 1288 | 32 | 8.36 | 3.83 | 1.11e-10 | 9.76e-10 | ID ASD | |
DB_ID:1627 | IL5-mediated signaling events | 1292 | 32 | 8.39 | 3.81 | 1.20e-10 | 9.76e-10 | ID ASD | |
DB_ID:1461 | GMCSF-mediated signaling events | 1292 | 32 | 8.39 | 3.81 | 1.20e-10 | 9.76e-10 | ID ASD | |
DB_ID:1602 | ErbB1 downstream signaling | 1288 | 32 | 8.36 | 3.83 | 1.11e-10 | 9.76e-10 | ID ASD | |
DB_ID:1554 | Arf6 signaling events | 1288 | 32 | 8.36 | 3.83 | 1.11e-10 | 9.76e-10 | ID ASD | |
DB_ID:1553 | Class I PI3K signaling events | 1288 | 32 | 8.36 | 3.83 | 1.11e-10 | 9.76e-10 | ID ASD | |
DB_ID:1472 | Nectin adhesion pathway | 1295 | 32 | 8.41 | 3.81 | 1.27e-10 | 9.76e-10 | ID ASD | |
DB_ID:1529 | IFN-gamma pathway | 1296 | 32 | 8.41 | 3.80 | 1.30e-10 | 9.76e-10 | ID ASD | |
DB_ID:1482 | IGF1 pathway | 1291 | 32 | 8.38 | 3.82 | 1.18e-10 | 9.76e-10 | ID ASD | |
DB_ID:1594 | S1P1 pathway | 1288 | 32 | 8.36 | 3.83 | 1.11e-10 | 9.76e-10 | ID ASD | |
DB_ID:1615 | Arf6 trafficking events | 1288 | 32 | 8.36 | 3.83 | 1.11e-10 | 9.76e-10 | ID ASD | |
DB_ID:1552 | Thrombin/protease-activated receptor (PAR) pathway | 1300 | 32 | 8.44 | 3.79 | 1.40e-10 | 9.76e-10 | ID ASD | |
DB_ID:1585 | Arf6 downstream pathway | 1288 | 32 | 8.36 | 3.83 | 1.11e-10 | 9.76e-10 | ID ASD | |
DB_ID:1648 | Class I PI3K signaling events mediated by Akt | 1288 | 32 | 8.36 | 3.83 | 1.11e-10 | 9.76e-10 | ID ASD | |
DB_ID:1603 | EGFR-dependent Endothelin signaling events | 1289 | 32 | 8.37 | 3.82 | 1.13e-10 | 9.76e-10 | ID ASD | |
DB_ID:1637 | Proteoglycan syndecan-mediated signaling events | 1345 | 33 | 8.73 | 3.78 | 7.68e-11 | 9.76e-10 | ID ASD | |
DB_ID:1571 | mTOR signaling pathway | 1288 | 32 | 8.36 | 3.83 | 1.11e-10 | 9.76e-10 | ID ASD | |
DB_ID:1531 | PAR1-mediated thrombin signaling events | 1299 | 32 | 8.43 | 3.79 | 1.38e-10 | 9.76e-10 | ID ASD | |
DB_ID:1509 | Internalization of ErbB1 | 1288 | 32 | 8.36 | 3.83 | 1.11e-10 | 9.76e-10 | ID ASD | |
DB_ID:1550 | EGF receptor (ErbB1) signaling pathway | 1288 | 32 | 8.36 | 3.83 | 1.11e-10 | 9.76e-10 | ID ASD | |
DB_ID:1573 | ErbB receptor signaling network | 1312 | 32 | 8.52 | 3.76 | 1.76e-10 | 1.16e-09 | ID ASD | |
DB_ID:1635 | Sphingosine 1-phosphate (S1P) pathway | 1311 | 32 | 8.51 | 3.76 | 1.73e-10 | 1.16e-09 | ID ASD | |
DB_ID:1480 | TRAIL signaling pathway | 1328 | 32 | 8.62 | 3.71 | 2.38e-10 | 1.54e-09 | ID ASD | |
DB_ID:1546 | Integrin-linked kinase signaling | 656 | 19 | 4.26 | 4.46 | 7.75e-08 | 4.88e-07 | ID ASD | |
DB_ID:1565 | AP-1 transcription factor network | 623 | 17 | 4.04 | 4.20 | 8.61e-07 | 5.29e-06 | ID ASD | |
DB_ID:1456 | Regulation of CDC42 activity | 770 | 18 | 5.00 | 3.60 | 3.61e-06 | 2.17e-05 | ID ASD | |
DB_ID:1488 | CDC42 signaling events | 757 | 17 | 4.91 | 3.46 | 1.13e-05 | 6.63e-05 | ID ASD | |
DB_ID:20 | Axon guidance | 219 | 9 | 1.42 | 6.33 | 1.49e-05 | 8.54e-05 | ID ASD | |
DB_ID:1435 | Wnt signaling network | 200 | 8 | 1.30 | 6.16 | 5.38e-05 | 0.0003 | ID ASD | |
DB_ID:1471 | Glypican 3 network | 206 | 8 | 1.34 | 5.98 | 6.61e-05 | 0.0004 | ID ASD | |
DB_ID:1604 | Syndecan-4-mediated signaling events | 209 | 8 | 1.36 | 5.90 | 7.32e-05 | 0.0004 | ID ASD | |
DB_ID:150 | Transmission across Chemical Synapses | 121 | 6 | 0.79 | 7.64 | 0.0001 | 0.0005 | ID ASD EE | |
DB_ID:487 | PLC beta mediated events | 39 | 4 | 0.25 | 15.80 | 0.0001 | 0.0005 | - | |
DB_ID:488 | G-protein mediated events | 40 | 4 | 0.26 | 15.40 | 0.0001 | 0.0005 | - | |
DB_ID:1451 | Signaling events mediated by HDAC Class I | 113 | 6 | 0.73 | 8.18 | 0.0001 | 0.0005 | - | |
DB_ID:1535 | Noncanonical Wnt signaling pathway | 182 | 7 | 1.18 | 5.92 | 0.0002 | 0.0009 | ID ASD | |
DB_ID:1493 | Validated targets of C-MYC transcriptional activation | 81 | 5 | 0.53 | 9.51 | 0.0002 | 0.0009 | ID ASD | |
DB_ID:143 | Neuronal System | 188 | 7 | 1.22 | 5.73 | 0.0002 | 0.0009 | ID ASD EE | |
DB_ID:1494 | N-cadherin signaling events | 251 | 8 | 1.63 | 4.91 | 0.0003 | 0.0014 | ID ASD | |
DB_ID:130 | Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | 89 | 5 | 0.58 | 8.65 | 0.0003 | 0.0014 | ID ASD EE | |
DB_ID:486 | Opioid Signalling | 53 | 4 | 0.34 | 11.62 | 0.0004 | 0.0017 | - | |
DB_ID:18 | Sema4D induced cell migration and growth-cone collapse | 22 | 3 | 0.14 | 21.00 | 0.0004 | 0.0017 | ASD | |
DB_ID:1467 | C-MYC pathway | 149 | 6 | 0.97 | 6.20 | 0.0004 | 0.0017 | ASD | |
DB_ID:1481 | LPA receptor mediated events | 100 | 5 | 0.65 | 7.70 | 0.0005 | 0.0021 | - | |
DB_ID:1542 | Canonical Wnt signaling pathway | 155 | 6 | 1.01 | 5.96 | 0.0006 | 0.0024 | ID ASD | |
DB_ID:11 | Developmental Biology | 433 | 10 | 2.81 | 3.56 | 0.0006 | 0.0024 | ID ASD | |
DB_ID:338 | Calmodulin induced events | 25 | 3 | 0.16 | 18.48 | 0.0006 | 0.0024 | ASD | |
DB_ID:339 | CaM pathway | 25 | 3 | 0.16 | 18.48 | 0.0006 | 0.0024 | ASD | |
DB_ID:16 | Sema4D in semaphorin signaling | 27 | 3 | 0.18 | 17.11 | 0.0007 | 0.0026 | ASD | |
DB_ID:323 | Phospholipase C-mediated cascade | 27 | 3 | 0.18 | 17.11 | 0.0007 | 0.0026 | ASD | |
DB_ID:336 | DAG and IP3 signaling | 27 | 3 | 0.18 | 17.11 | 0.0007 | 0.0026 | ASD | |
DB_ID:493 | Ca-dependent events | 27 | 3 | 0.18 | 17.11 | 0.0007 | 0.0026 | ASD | |
DB_ID:522 | Immune System | 532 | 11 | 3.45 | 3.18 | 0.0008 | 0.0028 | ID | |
DB_ID:186 | GABA B receptor activation | 28 | 3 | 0.18 | 16.50 | 0.0008 | 0.0028 | - | |
DB_ID:21 | Semaphorin interactions | 64 | 4 | 0.42 | 9.63 | 0.0008 | 0.0028 | ASD | |
DB_ID:183 | Activation of GABAB receptors | 28 | 3 | 0.18 | 16.50 | 0.0008 | 0.0028 | - | |
DB_ID:337 | EGFR interacts with phospholipase C-gamma | 29 | 3 | 0.19 | 15.93 | 0.0009 | 0.0030 | ASD | |
DB_ID:754 | Transport of Ribonucleoproteins into the Host Nucleus | 29 | 3 | 0.19 | 15.93 | 0.0009 | 0.0030 | - | |
DB_ID:1523 | Reelin signaling pathway | 29 | 3 | 0.19 | 15.93 | 0.0009 | 0.0030 | ID ASD | |
DB_ID:1539 | VEGFR1 specific signals | 29 | 3 | 0.19 | 15.93 | 0.0009 | 0.0030 | - | |
DB_ID:240 | PLC-gamma1 signalling | 30 | 3 | 0.19 | 15.40 | 0.0010 | 0.0033 | ASD | |
DB_ID:198 | Vpr-mediated nuclear import of PICs | 31 | 3 | 0.20 | 14.91 | 0.0011 | 0.0036 | - | |
DB_ID:846 | Glucagon signaling in metabolic regulation | 33 | 3 | 0.21 | 14.00 | 0.0013 | 0.0042 | ASD | |
DB_ID:200 | Interactions of Vpr with host cellular proteins | 34 | 3 | 0.22 | 13.59 | 0.0014 | 0.0044 | - | |
DB_ID:1662 | TGFBR | 125 | 5 | 0.81 | 6.16 | 0.0014 | 0.0044 | ID | |
DB_ID:643 | eNOS activation | 9 | 2 | 0.06 | 34.23 | 0.0015 | 0.0046 | - | |
DB_ID:1601 | p53 pathway | 189 | 6 | 1.23 | 4.89 | 0.0015 | 0.0046 | - | |
DB_ID:192 | GABA receptor activation | 36 | 3 | 0.23 | 12.84 | 0.0016 | 0.0048 | ASD EE | |
DB_ID:1094 | Innate Immune System | 190 | 6 | 1.23 | 4.86 | 0.0016 | 0.0048 | - | |
DB_ID:1593 | CXCR4-mediated signaling events | 192 | 6 | 1.25 | 4.81 | 0.0017 | 0.0050 | EE | |
DB_ID:494 | Adenylate cyclase activating pathway | 10 | 2 | 0.06 | 30.80 | 0.0018 | 0.0053 | - | |
DB_ID:1468 | Signaling events mediated by HDAC Class II | 38 | 3 | 0.25 | 12.16 | 0.0019 | 0.0054 | - | |
DB_ID:1577 | Glucocorticoid receptor regulatory network | 80 | 4 | 0.52 | 7.70 | 0.0019 | 0.0054 | - | |
DB_ID:1547 | Regulation of nuclear beta catenin signaling and target gene transcription | 135 | 5 | 0.88 | 5.70 | 0.0019 | 0.0054 | ID ASD | |
DB_ID:1469 | Stabilization and expansion of the E-cadherin adherens junction | 275 | 7 | 1.79 | 3.92 | 0.0023 | 0.0063 | ID ASD | |
DB_ID:1569 | Glucocorticoid receptor signaling | 85 | 4 | 0.55 | 7.25 | 0.0023 | 0.0063 | ASD | |
DB_ID:1544 | E-cadherin signaling in the nascent adherens junction | 275 | 7 | 1.79 | 3.92 | 0.0023 | 0.0063 | ID ASD | |
DB_ID:1617 | E-cadherin signaling events | 280 | 7 | 1.82 | 3.85 | 0.0025 | 0.0068 | ID ASD | |
DB_ID:636 | Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | 12 | 2 | 0.08 | 25.67 | 0.0027 | 0.0073 | - | |
DB_ID:185 | Adenylate cyclase inhibitory pathway | 13 | 2 | 0.08 | 23.70 | 0.0031 | 0.0081 | - | |
DB_ID:905 | Metabolism of carbohydrates | 92 | 4 | 0.60 | 6.70 | 0.0031 | 0.0081 | - | |
DB_ID:182 | Inhibition of adenylate cyclase pathway | 13 | 2 | 0.08 | 23.70 | 0.0031 | 0.0081 | - | |
DB_ID:756 | Meiotic Synapsis | 47 | 3 | 0.31 | 9.83 | 0.0036 | 0.0093 | ID | |
DB_ID:1611 | Regulation of nuclear SMAD2/3 signaling | 305 | 7 | 1.98 | 3.54 | 0.0040 | 0.0100 | ASD | |
DB_ID:1510 | TGF-beta receptor signaling | 305 | 7 | 1.98 | 3.54 | 0.0040 | 0.0100 | ASD | |
DB_ID:1440 | Regulation of cytoplasmic and nuclear SMAD2/3 signaling | 305 | 7 | 1.98 | 3.54 | 0.0040 | 0.0100 | ASD | |
DB_ID:146 | Muscle contraction | 50 | 3 | 0.32 | 9.24 | 0.0042 | 0.0103 | - | |
DB_ID:1614 | Angiopoietin receptor Tie2-mediated signaling | 50 | 3 | 0.32 | 9.24 | 0.0042 | 0.0103 | - | |
DB_ID:1438 | LPA4-mediated signaling events | 16 | 2 | 0.10 | 19.25 | 0.0047 | 0.0114 | ASD | |
DB_ID:1518 | Thromboxane A2 receptor signaling | 54 | 3 | 0.35 | 8.56 | 0.0053 | 0.0127 | - | |
DB_ID:1612 | ALK1 signaling events | 321 | 7 | 2.08 | 3.36 | 0.0053 | 0.0127 | - | |
DB_ID:847 | PKA activation in glucagon signalling | 17 | 2 | 0.11 | 18.12 | 0.0054 | 0.0128 | ASD | |
DB_ID:1583 | ALK1 pathway | 324 | 7 | 2.10 | 3.33 | 0.0055 | 0.0129 | - | |
DB_ID:640 | eNOS activation and regulation | 18 | 2 | 0.12 | 17.11 | 0.0060 | 0.0137 | - | |
DB_ID:1609 | ATR signaling pathway | 250 | 6 | 1.62 | 3.70 | 0.0061 | 0.0137 | - | |
DB_ID:917 | Fatty Acyl-CoA Biosynthesis | 18 | 2 | 0.12 | 17.11 | 0.0060 | 0.0137 | - | |
DB_ID:1665 | NOTCH | 57 | 3 | 0.37 | 8.11 | 0.0061 | 0.0137 | ASD | |
DB_ID:641 | Metabolism of nitric oxide | 18 | 2 | 0.12 | 17.11 | 0.0060 | 0.0137 | - | |
DB_ID:332 | PKA activation | 19 | 2 | 0.12 | 16.21 | 0.0067 | 0.0149 | - | |
DB_ID:333 | PKA-mediated phosphorylation of CREB | 20 | 2 | 0.13 | 15.40 | 0.0074 | 0.0162 | - | |
DB_ID:570 | Cholesterol biosynthesis | 20 | 2 | 0.13 | 15.40 | 0.0074 | 0.0162 | - | |
DB_ID:634 | Metabolism | 824 | 12 | 5.35 | 2.24 | 0.0081 | 0.0176 | ASD | |
DB_ID:1453 | Integrins in angiogenesis | 64 | 3 | 0.42 | 7.22 | 0.0084 | 0.0181 | - | |
DB_ID:484 | G alpha (z) signalling events | 22 | 2 | 0.14 | 14.00 | 0.0089 | 0.0190 | ASD | |
DB_ID:325 | Downstream signaling of activated FGFR | 66 | 3 | 0.43 | 7.00 | 0.0092 | 0.0195 | ASD | |
DB_ID:116 | NCAM1 interactions | 23 | 2 | 0.15 | 13.39 | 0.0097 | 0.0203 | ASD | |
DB_ID:981 | Regulation of Water Balance by Renal Aquaporins | 24 | 2 | 0.16 | 12.84 | 0.0106 | 0.0215 | ASD | |
DB_ID:520 | Cytosolic tRNA aminoacylation | 24 | 2 | 0.16 | 12.84 | 0.0106 | 0.0215 | - | |
DB_ID:1618 | Androgen-mediated signaling | 130 | 4 | 0.84 | 4.74 | 0.0104 | 0.0215 | ID | |
DB_ID:144 | Smooth Muscle Contraction | 24 | 2 | 0.16 | 12.84 | 0.0106 | 0.0215 | - | |
DB_ID:239 | HIV Infection | 204 | 5 | 1.32 | 3.78 | 0.0110 | 0.0222 | - | |
DB_ID:1274 | superpathway of cholesterol biosynthesis | 25 | 2 | 0.16 | 12.32 | 0.0114 | 0.0228 | - | |
DB_ID:758 | Meiosis | 72 | 3 | 0.47 | 6.42 | 0.0116 | 0.0230 | ID | |
DB_ID:749 | Influenza Life Cycle | 136 | 4 | 0.88 | 4.53 | 0.0122 | 0.0240 | - | |
DB_ID:1504 | S1P2 pathway | 26 | 2 | 0.17 | 11.85 | 0.0123 | 0.0240 | - | |
DB_ID:1664 | EGFR1 | 138 | 4 | 0.90 | 4.46 | 0.0128 | 0.0246 | ASD | |
DB_ID:1629 | Direct p53 effectors | 138 | 4 | 0.90 | 4.46 | 0.0128 | 0.0246 | - | |
DB_ID:467 | Downstream signal transduction | 75 | 3 | 0.49 | 6.16 | 0.0130 | 0.0248 | ASD | |
DB_ID:992 | Aquaporin-mediated transport | 27 | 2 | 0.18 | 11.41 | 0.0132 | 0.0250 | ASD | |
DB_ID:755 | Influenza Infection | 141 | 4 | 0.92 | 4.37 | 0.0137 | 0.0258 | - | |
DB_ID:201 | Host Interactions of HIV factors | 142 | 4 | 0.92 | 4.34 | 0.0140 | 0.0262 | - | |
DB_ID:254 | Signalling by NGF | 143 | 4 | 0.93 | 4.31 | 0.0144 | 0.0262 | ASD | |
DB_ID:920 | Triglyceride Biosynthesis | 28 | 2 | 0.18 | 11.00 | 0.0142 | 0.0262 | - | |
DB_ID:1121 | Negative regulators of RIG-I/MDA5 signaling | 28 | 2 | 0.18 | 11.00 | 0.0142 | 0.0262 | - | |
DB_ID:466 | Signaling by PDGF | 78 | 3 | 0.51 | 5.92 | 0.0144 | 0.0262 | ASD | |
DB_ID:1439 | Osteopontin-mediated events | 29 | 2 | 0.19 | 10.62 | 0.0152 | 0.0270 | - | |
DB_ID:740 | NEP/NS2 Interacts with the Cellular Export Machinery | 29 | 2 | 0.19 | 10.62 | 0.0152 | 0.0270 | - | |
DB_ID:901 | Regulation of Glucokinase by Glucokinase Regulatory Protein | 29 | 2 | 0.19 | 10.62 | 0.0152 | 0.0270 | - | |
DB_ID:1599 | ATM pathway | 307 | 6 | 1.99 | 3.01 | 0.0156 | 0.0276 | ID | |
DB_ID:4 | Nuclear import of Rev protein | 30 | 2 | 0.19 | 10.27 | 0.0162 | 0.0284 | - | |
DB_ID:1657 | Wnt | 82 | 3 | 0.53 | 5.64 | 0.0165 | 0.0288 | ID | |
DB_ID:812 | Integration of energy metabolism | 83 | 3 | 0.54 | 5.57 | 0.0170 | 0.0294 | ASD | |
DB_ID:742 | Export of Viral Ribonucleoproteins from Nucleus | 31 | 2 | 0.20 | 9.94 | 0.0173 | 0.0296 | - | |
DB_ID:476 | G alpha (s) signalling events | 31 | 2 | 0.20 | 9.94 | 0.0173 | 0.0296 | ASD | |
DB_ID:1512 | Posttranslational regulation of adherens junction stability and dissassembly | 231 | 5 | 1.50 | 3.33 | 0.0179 | 0.0304 | ID ASD | |
DB_ID:475 | G alpha (i) signalling events | 32 | 2 | 0.21 | 9.63 | 0.0183 | 0.0305 | ASD | |
DB_ID:203 | Rev-mediated nuclear export of HIV-1 RNA | 32 | 2 | 0.21 | 9.63 | 0.0183 | 0.0305 | - | |
DB_ID:387 | Transport of the SLBP independent Mature mRNA | 32 | 2 | 0.21 | 9.63 | 0.0183 | 0.0305 | - | |
DB_ID:392 | Transport of the SLBP Dependant Mature mRNA | 33 | 2 | 0.21 | 9.33 | 0.0194 | 0.0317 | - | |
DB_ID:5 | Interactions of Rev with host cellular proteins | 33 | 2 | 0.21 | 9.33 | 0.0194 | 0.0317 | - | |
DB_ID:1537 | Alpha4 beta1 integrin signaling events | 33 | 2 | 0.21 | 9.33 | 0.0194 | 0.0317 | - | |
DB_ID:142 | Post NMDA receptor activation events | 34 | 2 | 0.22 | 9.06 | 0.0206 | 0.0332 | ID ASD | |
DB_ID:140 | Activation of NMDA receptor upon glutamate binding and postsynaptic events | 34 | 2 | 0.22 | 9.06 | 0.0206 | 0.0332 | ID ASD | |
DB_ID:1095 | Toll Receptor Cascades | 90 | 3 | 0.58 | 5.13 | 0.0210 | 0.0337 | - | |
DB_ID:386 | Transport of Mature mRNA Derived from an Intronless Transcript | 35 | 2 | 0.23 | 8.80 | 0.0217 | 0.0346 | - | |
DB_ID:219 | Late Phase of HIV Life Cycle | 92 | 3 | 0.60 | 5.02 | 0.0223 | 0.0353 | - | |
DB_ID:393 | Transport of Mature mRNAs Derived from Intronless Transcripts | 36 | 2 | 0.23 | 8.56 | 0.0229 | 0.0360 | - | |
DB_ID:1457 | Notch-mediated HES/HEY network | 94 | 3 | 0.61 | 4.92 | 0.0235 | 0.0365 | ID ASD | |
DB_ID:1625 | Notch signaling pathway | 94 | 3 | 0.61 | 4.92 | 0.0235 | 0.0365 | ID ASD | |
DB_ID:1587 | Role of Calcineurin-dependent NFAT signaling in lymphocytes | 95 | 3 | 0.62 | 4.86 | 0.0242 | 0.0372 | - | |
DB_ID:306 | Signaling by FGFR | 95 | 3 | 0.62 | 4.86 | 0.0242 | 0.0372 | ASD | |
DB_ID:900 | Glucose transport | 38 | 2 | 0.25 | 8.11 | 0.0253 | 0.0386 | - | |
DB_ID:330 | Signaling by EGFR | 98 | 3 | 0.64 | 4.72 | 0.0262 | 0.0398 | ASD | |
DB_ID:903 | Hexose transport | 40 | 2 | 0.26 | 7.70 | 0.0279 | 0.0421 | - | |
DB_ID:1568 | amb2 Integrin signaling | 41 | 2 | 0.27 | 7.51 | 0.0292 | 0.0438 | - | |
DB_ID:229 | HIV Life Cycle | 103 | 3 | 0.67 | 4.49 | 0.0298 | 0.0444 | - | |
DB_ID:519 | tRNA Aminoacylation | 42 | 2 | 0.27 | 7.33 | 0.0305 | 0.0450 | - | |
DB_ID:858 | Regulation of mRNA Stability by Proteins that Bind AU-rich Elements | 104 | 3 | 0.68 | 4.44 | 0.0305 | 0.0450 | - | |
DB_ID:289 | NGF signalling via TRKA from the plasma membrane | 107 | 3 | 0.69 | 4.32 | 0.0328 | 0.0481 | ASD | |
DB_ID:1636 | Regulation of Androgen receptor activity | 108 | 3 | 0.70 | 4.28 | 0.0336 | 0.0490 | ID |